Duopharma Biotech achieves strong profitability in Q3 FY2025
Cumulative profits in first three quarters of FY2025 rise 43.8% year-on-year, boosted by 14% revenue growth in the same period compared to last year. Group achieves 11.7% increase in profits in Q3 FY2025 compared to… Read More »Duopharma Biotech achieves strong profitability in Q3 FY2025





